A Richter összeáll a Heteróval, fogyasztó gyógyszert fognak gyártani
Generikus (utángyártott, azonos hatóanyagot tartalmazó) Ozempic fejlesztésére, gyártására, terjesztésére kötött megállapodást a Richter a generikumokban utazó indiai Heteróval.
Richter Gedeon has entered into an agreement with Hetero, an Indian pharmaceutical company specializing in generics. The collaboration will focus on the development, manufacturing, and distribution of a generic version of Ozempic. This partnership aims to make a biosimilar of the widely used diabetes medication more accessible.
This agreement signifies Richter's expansion into the biosimilar market, potentially increasing competition and lowering the cost of a significant medication.
📌 Kaynak
Bu özet HVG (HU) kaynağından otomatik derlenmiştir. Tamamı için orijinal habere gidin.
Orijinal haberi oku →News AI World — Mobil uygulama
Bu haberleri 45 dilde, anlık çeviriyle cebinde. Erken erişim için Gmail adresini bırak.